Health News Roundup: FDA says widening probe on generic drug impurities; Possible link between C-section and autism, ADHD

Health News Roundup: FDA says widening probe on generic drug impurities; Possible link between C-section and autism, ADHD
Representative image Image Credit: ANI

Following is a summary of current health news briefs.

Football concussions tied to middle-age erectile dysfunction

Former professional U.S. football players with a history of concussions may be more likely to experience low testosterone and erectile dysfunction later in life, a recent study suggests. Researchers examined survey data collected from 3,409 mostly middle-aged former National Football League (NFL) players from 2015 to 2017. Overall, 18.3% of them had low testosterone and 22.7% had erectile dysfunction.

Global measles cases three times higher than last year: WHO

Every region in the world, expect the Americas, is experiencing an increase in the number of cases of measles, a vaccine-preventable disease that can kill or disable children, the World Health Organization (WHO) said on Thursday. The WHO's Kate O'Brien put the blame on weak health systems and misinformation about vaccines, and called on social media outlets and communities to make sure information about preventing the highly contagious disease was accurate.

FDA says widening probe on generic drug impurities

The U.S. Food and Drugs Administration said on Wednesday it was expanding its investigation into impurities in U.S. generic drugs beyond a class of medicines for high blood pressure known as angiotensin II receptor blockers (ARBs). The agency did not specify which types of additional drugs it was looking at, but said it was testing samples of other medicines with similar manufacturing processes to those in which concerning impurities have been discovered.

Pinterest will direct vaccine searches to major health groups

Pinterest Inc users searching for vaccine-related information will be shown results from leading public health groups, in an effort to combat health misinformation on the site, the social media company said in a blog post on Wednesday. The move is an aggressive effort to moderate content by the newly public social media company. Social media platforms have been increasingly under fire for promoting misleading and incorrect content, including by opponents of vaccination.

FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

The U.S. Food and Drug Administration said on Wednesday it had identified 63 cases of worsening liver function in certain patients taking hepatitis C medicines made by drugmakers Merck & Co Inc, Gilead Sciences and AbbVie Inc . The agency said that while the treatments are safe and effective, it had received reports of rare but serious instances of worsening liver function or failure when they were taken by patients with advanced liver disease.

U.S. to pay for thousands of doses of HIV drugs for Venezuelan migrants

The United States said on Wednesday it will provide thousands of doses of HIV medication to treat Venezuelans in Colombia as part of regional efforts to manage care for millions of migrants fleeing the crisis-hit nation. U.S. Health and Human Services (HHS) Secretary Alex Azar told Reuters about the decision in a phone interview following a meeting this week of health officials from 10 countries in the Colombian border city of Cucuta.

Purdue Pharma in a discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday. Purdue is among several drugmakers and distributors that have been sued for fueling an opioid addiction crisis in the United States, which claimed 400,000 lives from 1999 to 2017, according to the U.S. Centers for Disease Control and Prevention.

AstraZeneca respiratory business gets boost from 3-drug inhaler results

Prospects for AstraZeneca's respiratory treatments business improved on Wednesday as a three-drug inhaler was shown to ease smoker's lung and U.S. regulators granted its injectable asthma drug Fasenra special status for a rare lung condition. AstraZeneca said the late-stage ETHOS trial of triple-drug therapy Breztri Aerosphere, formerly known as PT010, helped patients suffering from chronic obstructive pulmonary disease (COPD), in a challenge to Glaxosmithkline's Trelegy Ellipta.

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight

A U.S. judge on Wednesday set aside a jury verdict that found Amgen Inc patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc and Sanofi SA, which sells a rival drug. The ruling from U.S. District Judge Richard Andrews in Wilmington, Delaware was the latest reversal of fortune in a long-running lawsuit in which Amgen is seeking to stop French drugmaker Sanofi and U.S. biotech Regeneron from selling their drug Praluent.

Possible link between C-section and autism, ADHD

The combined results of 61 studies conducted in 19 countries suggest that when a woman gives birth by cesarean section, autism in the child is 33% more likely and the odds of attention-deficit/hyperactivity disorder (ADHD) increase by 17%. The statistical analysis, published in JAMA Network Open, does not prove that having a C-section directly causes such problems. Other factors that lead doctors to order a surgical delivery of the baby may underlie the link.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.